HOTH Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Hoth Therapeutics Inc (HOTH.O) is -2.00, compared to its 5-year average forward P/E of -1.60. For a more detailed relative valuation and DCF analysis to assess Hoth Therapeutics Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.60

Current PE

-2.00

Overvalued PE

-0.71

Undervalued PE

-2.48

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-0.16

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

3.18

Undervalued EV/EBITDA

-3.49

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

HOTH News & Events

Events Timeline

No data

News

3.5

12-03PRnewswire

Hoth Therapeutics Advances Multiple Therapeutic Pipelines, Plans HT-KIT IND Submission in 2026

3.5

12-03Newsfilter

Hoth Therapeutics Advances Multiple Clinical Programs, IND Submission Expected in 2026

1.0

12-01PRnewswire

Hoth Therapeutics CEO Robb Knie to Present at NobleCon Conference

People Also Watch

Frequently Asked Questions

What is Hoth Therapeutics Inc (HOTH) stock price today?

The current price of HOTH is 1.05 USD — it has decreased -3.67 % in the last trading day.

What is Hoth Therapeutics Inc (HOTH)'s business?

Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The Company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).

What is the price predicton of HOTH Stock?

Wall Street analysts forecast HOTH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HOTH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Hoth Therapeutics Inc (HOTH)'s revenue for the last quarter?

Hoth Therapeutics Inc revenue for the last quarter amounts to -4.08M USD, increased 83.05 % YoY.

What is Hoth Therapeutics Inc (HOTH)'s earnings per share (EPS) for the last quarter?

Hoth Therapeutics Inc. EPS for the last quarter amounts to -2792672.00 USD, decreased % YoY.

What changes have occurred in the market's expectations for Hoth Therapeutics Inc (HOTH)'s fundamentals?

The market is revising No Change the revenue expectations for Hoth Therapeutics, Inc. (HOTH) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -42.62%.

How many employees does Hoth Therapeutics Inc (HOTH). have?

Hoth Therapeutics Inc (HOTH) has 2 emplpoyees as of December 17 2025.

What is Hoth Therapeutics Inc (HOTH) market cap?

Today HOTH has the market capitalization of 16.29M USD.